General sequencing reagent for next-generation sequencing reaction and preparation method of general sequencing reagent

By optimizing the combination of dNTP derivatives and PCR enhancers, the problem of the influence of existing sequencing reagents on DNA polymerase activity was solved, the stability of DNA libraries and PCR amplification efficiency were improved, high-quality sequencing data were achieved, and dependence on sequencers was reduced.

CN118995894AInactive Publication Date: 2024-11-22CHONGQING SUPER GENERATION GENE SEQUENCING TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411043408.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing sequencing reagents can easily affect the activity of DNA polymerase, leading to increased chemical bond residues, higher base mismatch probability, reduced DNA library stability and PCR amplification efficiency, and ultimately affecting sequencing quality.

Method used

A combination of four dNTP derivatives, DNA polymerase, and PCR enhancers, including compounds 1, 2, 3, and 4, and PCR enhancers bovine serum albumin, trehalose, polyvinylpyrrolidone, and 1-butyl-3-methylimidazolium bromide, was used. By optimizing the formulation and combining Canace DNA polymerase and Canace Buffer, residual chemical bonds were reduced, and the stability of the DNA library and the efficiency of PCR amplification were improved.

Benefits of technology

It reduces the probability of base mismatches, improves the quality of sequencing data and PCR amplification efficiency, simplifies the requirements for sequencers, and is conducive to the popularization of next-generation sequencing technology.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention provides a general sequencing reagent for a next-generation sequencing reaction and a preparation method of the general sequencing reagent, and belongs to the technical field of preparation of sequencing reagents of nucleic acid sequencers. The universal sequencing reagent is prepared from the following raw material components: four dNTPs derivatives, DNA polymerase, Buffer and a PCR (Polymerase Chain Reaction) enhancer, the PCR reinforcing agent is a combination of bovine serum albumin (BSA), trehalose, polyvinylpyrrolidone (PVP) and 1-butyl-3-methylimidazolium bromide ([BMIm] Br). The sequencing reagent disclosed by the invention does not influence the activity of DNA polymerase, reduces the residual of chemical bonds, reduces the probability of base mismatch, can increase the stability of a DNA library and the amplification efficiency of PCR, and improves the quality of sequencing data; and meanwhile, sequencing of the DNA library can be realized only by an excitation light source and a camera, so that the requirement on a sequencer is reduced, and downward popularization of a next-generation sequencing technology and the next-generation sequencer is facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of nucleic acid sequencer sequencing reagent preparation, and in particular relates to a universal sequencing reagent for second-generation sequencing reaction and a preparation method thereof. Background Art

[0002] High-throughput sequencing is a DNA sequencing technology developed based on PCR (Polymerase Chain Reaction) and gene chips. High-throughput sequencers are a type of molecular biology experimental equipment commonly used in the field of biology. They are mainly used to sequence DNA, RNA, proteins and other molecules quickly, with high precision and high throughput. Next-generation sequencing (NGS), also known as high-throughput sequencing, is a DNA sequencing technology developed based on PCR and gene chips. During the DNA replication process, second-generation sequencing determines the sequence of DNA by capturing the special markers (usually fluorescent molecular markers) carried by the newly added bases. Existing technology platforms mainly include Roche's 454FLX, Illumina's Miseq / Hiseq and BGI's DNBSEQ.

[0003] In the most popular Illumina Miseq / Hiseq platform, different fluorescent groups are labeled with four reversible termination nucleotides (NRT) and added to the reaction to distinguish different base sequences. These fluorescent groups are connected to the bases through cleavable chains, and an azide group is added to the 3'-OH end for protection.

[0004] Currently, the fluorescent dye markers modified on NRT are connected to the bases through cleavable chains. During the elution process, some of the connected chains may remain. These residual chemical bonds will affect the extension of the polymerase and greatly increase the probability of base complementary mismatches, reducing the flexibility of the new chain, thereby affecting the sequencing quality and interfering with the judgment of the results.

[0005] Existing sequencing reagents, due to the complex chemical structure of the dNTP derivatives involved and the complex synthesis process, may produce erroneous compounds, affecting the labeling of fluorescent groups. At the same time, since sequencing reagents affect the activity of DNA polymerase, resulting in residual chemical bonds and increased base mismatch probability, and the stability of DNA libraries and PCR amplification efficiency of existing sequencing reagents are often poor, the quality of sequencing data needs to be improved urgently.

[0006] Therefore, how to develop a gene sequencing reagent that will not affect the activity of DNA polymerase, reduce the residual chemical bonds and reduce the probability of base mismatching, and increase the stability of the DNA library and the amplification efficiency of PCR, and improve the quality of sequencing data, has become a technical problem that the present invention needs to solve. Summary of the invention

[0007] The present invention is to solve the above technical problems, thereby providing a universal sequencing reagent for the second generation sequencing reaction and a preparation method thereof. The technical purpose of the present invention is to solve the problem that the existing sequencing reagents are easy to affect the activity of DNA polymerase, easily cause chemical bond residues and increase the probability of base mismatch, and solve the problem that the existing sequencing reagents have low stability of the DNA library and low PCR amplification efficiency during sequencing, thereby providing a sequencing reagent with excellent sequencing quality.

[0008] In order to achieve the above technical objectives, the present invention adopts the following technical solutions:

[0009] The present invention first provides a universal sequencing reagent for a second-generation sequencing reaction, which includes the following raw material components: four dNTPs derivatives, DNA polymerase, Buffer and PCR enhancer;

[0010] The four dNTPs derivatives include compound 1, compound 2, compound 3 and compound 4, all of which are 2'-deoxynucleotide derivatives having a structure as shown in formula <Ⅰ>:

[0011]

[0012] Formula <Ⅰ> Chemical structures of compounds 1, 2, 3, and 4

[0013] Wherein, R1 is a base; L1 is any one of the cleavable linking groups; R2 and R3 are fluorescent groups or do not exist; R4 is a phosphate group; R5 is a protecting group capable of orthogonal cleavage reaction;

[0014] The base is adenine, guanine, thymine or cytosine;

[0015] L1 is any of the following cleavable linkers:

[0016]

[0017] R5 is a protecting group of any of the following structures:

[0018]

[0019] The PCR enhancer is composed of a combination of bovine serum albumin (BSA), trehalose, polyvinyl pyrrolidone (PVP), and 1-butyl-3-methylimidazolium bromide ([BMIm]Br), wherein the concentration of bovine serum albumin is 1-10 mg / mL, the concentration of trehalose is 0.1-1 mol / L, the concentration of polyvinyl pyrrolidone is 5-100 mg / mL, and the concentration of 1-butyl-3-methylimidazolium bromide is 1.0-2.0 mol / L.

[0020] In order to improve the problem of library mismatch affecting the quality of sequencing data during sequencing, the inventors have conducted a lot of exploration on the formula of the test reagent, and finally selected the above formula of the present invention. The above connecting chain is used as the connecting chain of the dNTP derivative, and the fluorescent group is connected to the base through the connecting chain, thereby forming four compounds in the dNTPs derivative mixed solution, and then matched with the excellent performance Canace DNA polymerase, Canace Buffer and PCR enhancer, thereby forming the sequencing reagent of the present invention.

[0021] The universal gene sequencing reagent provided by the present invention includes 2′, 3′-dideoxytriphosphate nucleotide derivatives, the first feature of which is that the O between the first and second phosphate groups at the 5′-end is replaced by a CH2 group, and the second feature is that the base of the nucleotide polyphosphate derivative is marked with a fluorescent group or a reactive group. Affected by the damaged phosphate group, the NTP in the reagent cannot form a phosphodiester bond normally, and the DNA chain extension is terminated. The nucleotide derivative incorporated at the 3′ end of the nucleic acid chain is identified by detecting the fluorescent label of each incorporated nucleotide derivative and taking a photo to store the image, and the base at the corresponding position on the DNA template is judged accordingly. The present invention provides four-color fluorescence and two-color fluorescence, which can be adapted to multiple models of sequencers. In addition, the combination of DNA polymerase and PCR enhancer involved in the present invention can further improve the high fidelity of PCR amplification reaction. Bovine serum albumin and polyvinyl pyrrolidone can competitively aggregate at the oil-water interface, thereby reducing the interfacial adsorption of DNA polymerase; bovine serum albumin can improve the amplification efficiency of PCR reaction; trehalose can improve the thermal stability of DNA polymerase, reduce the melting temperature of DNA template, and reduce the secondary structure formed by self-complementary pairing in GC-rich regions, thereby improving the specificity of PCR reaction. 1-Butyl-3-methylimidazolium bromide can improve the stability of DNA structure and increase PCR amplification efficiency.

[0022] The sequencing reagent of the present invention only requires an excitation light source and a camera to sequence a DNA library, which reduces the requirements for sequencers and is conducive to the popularization of second-generation sequencing technology and second-generation sequencers.

[0023] Furthermore, the R1 is any one of the following four base structures:

[0024]

[0025] Furthermore, R2 and R3 include any one of the following fluorescent groups: AF350, AF568, AF488, AF430.

[0026] Furthermore, the R4 is a monophosphate group or a polyphosphate group.

[0027] Furthermore, the structural formulas corresponding to Compound 1, Compound 2, Compound 3, and Compound 4 are as follows:

[0028]

[0029]

[0030] Furthermore, the concentration of bovine serum albumin is 5 mg / mL; the concentration of trehalose is 0.6 mol / L; the concentration of polyvinyl pyrrolidone is 55 mg / mL; and the concentration of 1-butyl-3-methylimidazolium bromide is 1.5 mol / L.

[0031] Furthermore, the DNA polymerase is Canace DNA polymerase.

[0032] Furthermore, the Buffer is a Canace Buffer.

[0033] Furthermore, the concentrations of the four dNTPs derivatives in the sequencing reagent are all 2.5 mM.

[0034] A second object of the present invention is to provide a method for preparing the universal sequencing reagent for the second generation sequencing reaction as described above, comprising the following steps:

[0035] (1) Compound 1, Compound 2, Compound 3, and Compound 4 were prepared respectively, and the above four compounds were dissolved in Tris-HCl buffer (pH 7.2) containing 0.1 wt% Proclin to a concentration of 10 mM; the four compound solutions were mixed in equal volumes and the corresponding concentrations were measured at different wavelengths to adjust the concentration of each compound to 2.5 mM, and then filtered to remove impurities;

[0036] (2) bovine serum albumin, trehalose, polyvinyl pyrrolidone and [BMIm]Br are weighed according to the required amounts, dissolved and fixed to volume, and then Proclin is added to a concentration of 0.1 wt %, and then a PCR enhancer is prepared according to the required concentration;

[0037] (3) The four compounds prepared in step (1) are mixed to prepare a dNTPs derivative mixed solution, which is then mixed with the PCR enhancer prepared in step (2), as well as DNA polymerase and 1×Buffer to prepare a universal sequencing reagent for the second-generation sequencing reaction.

[0038] The beneficial effects of the present invention are as follows:

[0039] (1) The sequencing reagent of the present invention comprises four compounds constituting a mixed solution of dNTPs derivatives, and is matched with Canace DNA polymerase, Canace Buffer and PCR enhancer with excellent performance. The sequencing reagent will not affect the activity of DNA polymerase, can reduce the residual chemical bonds and the probability of base mismatch, and can increase the stability of the DNA library and the amplification efficiency of PCR, thereby improving the quality of sequencing data.

[0040] (2) The sequencing reagent of the present invention only requires an excitation light source and a camera to sequence a DNA library, which reduces the requirements for sequencers and is conducive to the popularization of second-generation sequencing technology and second-generation sequencers. DETAILED DESCRIPTION

[0041] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is described in detail below in conjunction with the embodiments. It is necessary to point out that the following embodiments are only used to explain and illustrate the present invention and are not used to limit the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the above invention content still belong to the protection scope of the present invention.

[0042] Example 1

[0043] A second-generation sequencing universal dNTP derivative mixed solution is used for a second-generation sequencer capable of collecting four-color fluorescence, wherein the concentrations of dATP derivatives, dGTP derivatives, dCTP derivatives, and dTTP derivatives are 2.5 mM respectively. The preparation method of the second-generation sequencing reaction universal dNTP derivative mixed solution is as follows:

[0044] Compound 1, Compound 2, Compound 3, and Compound 4 were prepared respectively, which are 2'-deoxynucleotide derivatives having the structure shown in Formula <Ⅱ>, where Base represents different bases:

[0045]

[0046] Formula <Ⅱ> Basic structure of compounds 1, 2, 3, 4

[0047] Its synthetic route is as follows:

[0048]

[0049] In this embodiment, the structural formulas corresponding to Compound 1, Compound 2, Compound 3, and Compound 4 are as follows:

[0050]

[0051] The above four compounds were dissolved in Tris-HCl buffer (pH 7.2) containing 0.1 wt% Proclin to a concentration of 10 mM. The four compound solutions were mixed in equal volumes and the corresponding concentrations were measured at different wavelengths to adjust the concentration of each compound to 2.5 mM. After filtering and removing impurities, the solutions were packaged according to actual needs.

[0052] The parameters of the total dNTP mixed solution composed of the four compounds are shown in Table 1:

[0053] Table 1 Total dNTP mixed solution

[0054] Base wavelength Digestibility A 259 <![CDATA[1.54*10 4 <!-- 6 -->]]> G 253 <![CDATA[1.37*10 4 ]]> C 271 <![CDATA[9.10*10 3 ]]> T 260 <![CDATA[7.40*10 3 ]]>

[0055] The PCR enhancer in the present invention is a combination of bovine serum albumin, trehalose, polyvinyl pyrrolidone, and [BMIm]Br. Among them, the concentration of bovine serum albumin can be 1-10 mg / mL; the concentration of trehalose can be 0.1-1 mol / L; the concentration of polyvinyl pyrrolidone can be 5-100 mg / mL; the concentration of [BMIm]Br can be 1.0-2.0 mol / L. In this embodiment, the composition of the PCR enhancer is: the concentration of bovine serum albumin is 5 mg / mL; the concentration of trehalose is 0.6 mol / L; the concentration of polyvinyl pyrrolidone is 55 mg / mL; and the concentration of [BMIm]Br is 1.5 mol / L.

[0056] The above dNTP derivative mixture, Canace DNA polymerase, 1×Canace Buffer and PCR enhancer were mixed to prepare the sequencing reagent of the present invention, which was used for second-generation sequencing. The sequencing sample was a free DNA fragment, and the sequencing mode was a single-end 75 bases. The sequencing results and analysis are shown in Table 2 below:

[0057] Table 2. General reagents for this sequencing reaction involved in sequencing results and analysis

[0058]

[0059]

[0060] Example 2

[0061] The sequencing reagent of the present invention was prepared by referring to the formula and method of Example 1, wherein the PCR enhancer is a combination of bovine serum albumin, trehalose, and polyvinyl pyrrolidone. The concentration of bovine serum albumin is 1 mg / mL; the concentration of trehalose is 0.1 mol / L; the concentration of polyvinyl pyrrolidone is 5 mg / mL; and the concentration of [BMIm]Br is 1.0 mol / L. The sequencing results are similar to those in Table 2.

[0062] Example 3

[0063] The sequencing reagent of the present invention was prepared by referring to the formula and method of Example 1, wherein the PCR enhancer is a combination of bovine serum albumin, trehalose, and polyvinyl pyrrolidone. The concentration of bovine serum albumin is 10 mg / mL; the concentration of trehalose is 1 mol / L; the concentration of polyvinyl pyrrolidone is 100 mg / mL; and the concentration of [BMIm]Br is 2.0 mol / L. The sequencing results are similar to those in Table 2.

[0064] Comparative Example 1

[0065] The sequencing reagent was prepared with reference to the formula and method of Example 1, wherein the PCR enhancer was a combination of bovine serum albumin, trehalose and polyvinyl pyrrolidone. The study compared the sequencing data quality when the PCR enhancer was added during the second generation sequencing, and the experimental results are shown in Table 3. As can be seen from Table 3, the use of the enhancer of the present invention can significantly improve the amount of sequencing data and the data quality of the high GC content library.

[0066] Table 3 Effect of PCR enhancers on data quality in next-generation sequencing

[0067]

[0068]

[0069] Comparative Example 2

[0070] 1-Butyl-3-methylimidazolium bromide ([BMIm]Br) was added to the PCR enhancer of Comparative Example 1, and the sequencing conditions were further optimized. The concentration of [BMIm]Br was 1.5 mol / L. The study compared whether adding [BMIm]Br as a PCR enhancer during the second generation sequencing could achieve better results, and the experimental results are shown in Table 4. As can be seen from Table 4, the use of a PCR enhancer containing [BMIm]Br can significantly improve the amount of sequencing data and the quality of data from the high GC content library.

[0071] Table 4 Effect of [BMIm]Br as a PCR enhancer component on data quality in next-generation sequencing

[0072]

[0073] Comparative Example 3

[0074] EDTA and ammonium acetate were selected to replace 1-butyl-3-methylimidazolium bromide ([BMIm]Br) as DNA structure stabilizers, and each was added to the PCR enhancer of Comparative Example 1 to prepare sequencing reagents, and the sequencing conditions were further optimized. The concentration of EDTA was 0.1mol / L, the concentration of ammonium acetate was 10mmol / L, and the concentration of [BMIm]Br was 1.5mol / L. The study compared the addition of different components that promote DNA structure stability as PCR enhancers during second-generation sequencing to achieve better results, and the experimental results are shown in Table 5. As can be seen from Table 5, the use of a PCR enhancer containing [BMIm]Br has the best effect on the sequencing results of the sequencing reagent compared with PCR enhancers composed of other alternative compositions.

[0075] Table 5 Effects of PCR enhancers with different DNA structure stabilizer compositions on data quality for next-generation sequencing

[0076]

Claims

1. A universal sequencing reagent for the second generation sequencing reaction, characterized in that: The raw material components include: four dNTPs derivatives, DNA polymerase, buffer and PCR enhancer; The four dNTPs derivatives include compound 1, compound 2, compound 3 and compound 4, all of which are 2'-deoxynucleotide derivatives having a structure as shown in formula <Ⅰ>: Formula <Ⅰ> Chemical structures of compounds 1, 2, 3, and 4 Wherein, R1 is a base; L1 is any one of the cleavable linking groups; R2 and R3 are fluorescent groups or do not exist; R4 is a phosphate group; R5 is a protecting group capable of orthogonal cleavage reaction; The base is adenine, guanine, thymine or cytosine; L1 is any of the following cleavable linkers: R5 is a protecting group of any of the following structures: The PCR enhancer is composed of a combination of bovine serum albumin, trehalose, polyvinyl pyrrolidone and 1-butyl-3-methylimidazolium bromide, wherein the concentration of bovine serum albumin is 1-10 mg / mL, the concentration of trehalose is 0.1-1 mol / L, the concentration of polyvinyl pyrrolidone is 5-100 mg / mL, and the concentration of 1-butyl-3-methylimidazolium bromide is 1.0-2.0 mol / L.

2. The universal sequencing reagent for the second generation sequencing reaction according to claim 1, characterized in that: The R1 is any one of the following four base structures:

3. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The R2 and R3 include any one of the following fluorescent groups: AF350, AF568, AF488, AF430.

4. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The R4 is a monophosphate group or a polyphosphate group.

5. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The structural formulas corresponding to the compounds 1, 2, 3 and 4 are as follows:

6. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The concentration of bovine serum albumin is 5 mg / mL; the concentration of trehalose is 0.6 mol / L; the concentration of polyvinyl pyrrolidone is 55 mg / mL; and the concentration of 1-butyl-3-methylimidazolium bromide is 1.5 mol / L.

7. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The DNA polymerase is Canace DNA polymerase.

8. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The Buffer is Canace Buffer.

9. The universal sequencing reagent for the second generation sequencing reaction according to claim 1 or 2, characterized in that: The concentrations of the four dNTPs derivatives in the sequencing reagent are all 2.5 mM.

10. The method for preparing a universal sequencing reagent for a second generation sequencing reaction according to any one of claims 1 to 9, characterized in that: The following steps are involved: (1) Compound 1, Compound 2, Compound 3, and Compound 4 were prepared respectively, and the above four compounds were dissolved in Tris-HCl buffer containing 0.1 wt% Proclin to a concentration of 10 mM; the four compound solutions were mixed in equal volumes and the corresponding concentrations were measured at different wavelengths to adjust the concentration of each compound to 2.5 mM, and then filtered to remove impurities; (2) bovine serum albumin, trehalose, polyvinyl pyrrolidone and [BMIm]Br are weighed according to the required amounts, dissolved and fixed to volume, and then Proclin is added to a concentration of 0.1 wt %, and then a PCR enhancer is prepared according to the required concentration; (3) The four compounds prepared in step (1) are mixed to prepare a dNTPs derivative mixed solution, which is then mixed with the PCR enhancer prepared in step (2), as well as DNA polymerase and 1×Buffer to prepare a universal sequencing reagent for the second-generation sequencing reaction.